Xenolis

Biotechnology Research • Queenstown, Central Region, Singapore • 1-10 Employees

Company overview

Headquarters	79 Science Park Drive, #06-01/08, Singapore, 118264, SG
Website	xenolis.com
Keywords	Diagnostics, Proteomic Screening, Xenoaptamers
Founded	2022
Employees	1-10
Socials

Key Contacts at Xenolis

Chee Min Chua

Cofounder, Chief Executive Officer

Michiko Kimoto

Coo, R&D Director

Xenolis Email Formats

Xenolis uses 1 email format. The most common is {first name}.{last name} (e.g., john.doe@xenolis.com), used 100% of the time.

Format	Example	Percentage
{first name}.{last name}	john.doe@xenolis.com	100%

About Xenolis

A novel platform technology that uses unnatural base pairs to create xenoaptamers with more combinations and characteristics. These synthetic oligonucleotides generated via genetic alphabet can be used for diagnostics, biosensing, imaging, therapeutics and more.

Xenolis revenue & valuation

Annual revenue	$855,550
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$2,800,000
Total funding	No funding

Employees by Management Level

Total employees: 1-10

Seniority

Employees

C-Suite

Entry

Founder/Owner

Employees by Department

Xenolis has 6 employees across 3 departments.

Departments

Number of employees

Funding Data

Xenolis has never raised funding before.

Frequently asked questions

Xenolis is located in Queenstown, Central Region, SG.

Xenolis was founded in 2022, making it 4 years old. The company has established itself as a significant player in its industry over this time.

Xenolis has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Key Contacts at Xenolis

Chee Min Chua

Cofounder, Chief Executive Officer

Michiko Kimoto

Coo, R&D Director

4.8

40,000 users